Immune & Inflammatory

Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study – E BioMedicine, October 2016

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study – Diabetes Care, July 2015

Mesenchymal Precursor Cell Therapy for Diabetic Nephropathy: A Phase 2 Randomized Controlled Trial – 75^thScientific Sessions of the American Diabetes Association, June 2015

Effect of Mesenchymal Precursor Cells on the Systemic Inflammatory Response and Endothelial Dysfunction in an Ovine Model of Collagen-Induced Arthritis – PLOS One, May 2015

Treatment of Inflammatory Diseases with Mesenchymal Stem Cells – Inflammation & Allergy, 2009